trending Market Intelligence /marketintelligence/en/news-insights/trending/-5xhH6MBx24KW6afmPmgAg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Fitch revises outlook on Banestes' national rating to positive

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible


Fitch revises outlook on Banestes' national rating to positive

Fitch Ratings changed the outlook of Banestes SA - Banco do Estado do Espírito Santo's national long-term rating to positive from stable after affirming it at A+(bra).

The rating agency cited "an improvement in Fitch's core metrics for profitability, capitalization and liquidity through a more challenging economic cycle relative to similarly rated peers on the national scale."

Fitch also pointed to the bank's moderate risk appetite, management quality and financial profile in the decision. The rating agency did highlight that as a public entity, "Banestes is potentially subject to political influence, given its control structure, despite its solid corporate governance structure."

The rating agency also affirmed its long- and short-term foreign and local currency issuer default ratings at BB- and B, respectively. The lender's national short-term rating and viability rating were also affirmed at F1(bra) and "bb-," respectively.